Skip to main content
. 2020 Nov 23;39(7):2545–2552. doi: 10.1007/s00345-020-03522-3

Fig. 1.

Fig. 1

Survival curves for analysed subgroups. a Recurrence-free survival (TTBCG intervals: 6–10; 11–14; 15–18 and 19–25 weeks) (p = 0.152). b Progression-free survival (TTBCG intervals: 6–10; 11–14; 15–18 and 19–25 weeks) (p = 0.021). c Recurrence-free survival (TTBCG intervals: ≤ 101 and > 101 days) (p = 0.006). d Progression-free survival (TTBCG intervals: 101 and > 101 days) (p = 0.018)